These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3839860)

  • 1. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
    Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
    Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
    Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
    Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
    Igarashi Y; Aizawa Y; Tamura M; Ebe K; Yamaguchi T; Shibata A
    Am Heart J; 1989 Oct; 118(4):674-8. PubMed ID: 2679015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart.
    Rioux F; Bachelard H; Martel JC; St-Pierre S
    Peptides; 1986; 7(1):27-31. PubMed ID: 3754963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmural regulation of myocardial perfusion by neuropeptide Y.
    Gutterman DD; Morgan DA
    Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of angiotensin-converting enzyme inhibition with vasoactive peptides in the coronary circulation of dogs.
    Bauer B; Neubauer S; Spindler M; Dürr R; Becker HH; Ertl G
    J Cardiovasc Pharmacol; 1995 May; 25(5):756-62. PubMed ID: 7630154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of inhibition of endothelium-derived nitric oxide formation to effects of vasoconstrictor agents neuropeptide Y, clonidine, and ergonovine on coronary vascular resistance.
    Tsunoda R; Okumura K; Ishizaka H; Matsunaga T; Yasue H
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):87-94. PubMed ID: 7521496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
    Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
    Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
    Martin SE; Tidmore WC; Patterson RE
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs.
    Ertl G; Bauer B; Becker HH; Rose G
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1062-8. PubMed ID: 8476083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart.
    Komaru T; Ashikawa K; Kanatsuka H; Sekiguchi N; Suzuki T; Takishima T
    Circ Res; 1990 Nov; 67(5):1142-51. PubMed ID: 2225353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cardiac distribution and function of neuropeptide Y.
    Allen JM; Gjörstrup P; Björkman JA; Ek L; Abrahamsson T; Bloom SR
    Acta Physiol Scand; 1986 Mar; 126(3):405-11. PubMed ID: 3754377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.